1. Home
  2. SWTX vs MRCY Comparison

SWTX vs MRCY Comparison

Compare SWTX & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • MRCY
  • Stock Information
  • Founded
  • SWTX 2017
  • MRCY 1981
  • Country
  • SWTX United States
  • MRCY United States
  • Employees
  • SWTX N/A
  • MRCY N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • MRCY
  • Sector
  • SWTX Health Care
  • MRCY
  • Exchange
  • SWTX Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • SWTX 3.0B
  • MRCY 2.7B
  • IPO Year
  • SWTX 2019
  • MRCY 1998
  • Fundamental
  • Price
  • SWTX $58.25
  • MRCY $42.51
  • Analyst Decision
  • SWTX Strong Buy
  • MRCY Hold
  • Analyst Count
  • SWTX 6
  • MRCY 7
  • Target Price
  • SWTX $70.83
  • MRCY $42.14
  • AVG Volume (30 Days)
  • SWTX 3.2M
  • MRCY 613.9K
  • Earning Date
  • SWTX 02-20-2025
  • MRCY 02-04-2025
  • Dividend Yield
  • SWTX N/A
  • MRCY N/A
  • EPS Growth
  • SWTX N/A
  • MRCY N/A
  • EPS
  • SWTX N/A
  • MRCY N/A
  • Revenue
  • SWTX $191,589,000.00
  • MRCY $884,377,000.00
  • Revenue This Year
  • SWTX $3,475.18
  • MRCY $3.92
  • Revenue Next Year
  • SWTX $81.60
  • MRCY $6.30
  • P/E Ratio
  • SWTX N/A
  • MRCY N/A
  • Revenue Growth
  • SWTX 3417.33
  • MRCY N/A
  • 52 Week Low
  • SWTX $28.21
  • MRCY $26.48
  • 52 Week High
  • SWTX $62.00
  • MRCY $52.25
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 70.71
  • MRCY 45.69
  • Support Level
  • SWTX $54.89
  • MRCY $43.64
  • Resistance Level
  • SWTX $62.00
  • MRCY $52.25
  • Average True Range (ATR)
  • SWTX 4.09
  • MRCY 1.95
  • MACD
  • SWTX 1.35
  • MRCY -0.38
  • Stochastic Oscillator
  • SWTX 85.90
  • MRCY 18.90

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: